thyroxine has been researched along with Minimal Disease, Residual in 11 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thyrotropin-secreting pituitary adenomas (TSHomas) are a rare entity, occurring in one per million people." | 2.72 | ENDOCRINE TUMOURS: Thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases. ( De Block, C; De Herdt, C; Philipse, E, 2021) |
| "Differentiated thyroid cancer is increasing in prevalence." | 2.46 | Postoperative management of differentiated thyroid cancer. ( Kim, M; Sabet, A, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| De Herdt, C | 1 |
| Philipse, E | 1 |
| De Block, C | 1 |
| Campennì, A | 1 |
| Amato, E | 1 |
| Laudicella, R | 1 |
| Alibrandi, A | 1 |
| Cardile, D | 1 |
| Pignata, SA | 1 |
| Trimarchi, F | 1 |
| Ruggeri, RM | 1 |
| Auditore, L | 1 |
| Baldari, S | 1 |
| Karppinen, A | 1 |
| Kivipelto, L | 1 |
| Vehkavaara, S | 1 |
| Ritvonen, E | 1 |
| Tikkanen, E | 1 |
| Kivisaari, R | 1 |
| Hernesniemi, J | 1 |
| Setälä, K | 1 |
| Schalin-Jäntti, C | 1 |
| Niemelä, M | 1 |
| Karga, H | 1 |
| Papaioannou, G | 1 |
| Polymeris, A | 1 |
| Papamichael, K | 1 |
| Karpouza, A | 1 |
| Samouilidou, E | 1 |
| Papaioannou, P | 1 |
| Sabet, A | 1 |
| Kim, M | 1 |
| Pacini, F | 1 |
| Kasner, DL | 1 |
| Spieth, ME | 1 |
| Starkman, ME | 1 |
| Zdor-North, D | 1 |
| Robbins, RJ | 1 |
| Larson, SM | 1 |
| Sinha, N | 1 |
| Shaha, A | 1 |
| Divgi, C | 1 |
| Pentlow, KS | 1 |
| Ghossein, R | 1 |
| Tuttle, RM | 1 |
| Giusti, M | 1 |
| Zoccola, R | 1 |
| Guazzini, B | 1 |
| Molinari, E | 1 |
| Valenti, S | 1 |
| Villa, G | 1 |
| Bertolazzi, L | 1 |
| Minuto, F | 1 |
| Golger, A | 1 |
| Fridman, TR | 1 |
| Eski, S | 1 |
| Witterick, IJ | 1 |
| Freeman, JL | 1 |
| Walfish, PG | 1 |
| Maciel, RM | 1 |
4 reviews available for thyroxine and Minimal Disease, Residual
| Article | Year |
|---|---|
ENDOCRINE TUMOURS: Thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases.
Topics: Adenoma; Atrial Fibrillation; Chemotherapy, Adjuvant; Goiter; Gonadotropins, Pituitary; Growth Hormo | 2021 |
Postoperative management of differentiated thyroid cancer.
Topics: Adenocarcinoma, Papillary; Carcinoma, Medullary; Combined Modality Therapy; Follow-Up Studies; Human | 2010 |
Follow-up of differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Autoantibodies; Biomarkers, Tumor; Carcinoma, Papillary; Combined Modali | 2002 |
[Will the thyroglobulin assay with lower functional sensitivity whilst the patients are on L-T4 treatment replace the TSH-stimulated thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer?].
Topics: Algorithms; Biological Assay; Carcinoma; Humans; Neoplasm Recurrence, Local; Neoplasm, Residual; Pra | 2007 |
7 other studies available for thyroxine and Minimal Disease, Residual
| Article | Year |
|---|---|
Recombinant human thyrotropin (rhTSH) versus Levo-thyroxine withdrawal in radioiodine therapy of differentiated thyroid cancer patients: differences in abdominal absorbed dose.
Topics: Abdomen; Adenocarcinoma; Drug Administration Schedule; Female; Gastrointestinal Absorption; Humans; | 2019 |
Transition From Microscopic to Endoscopic Transsphenoidal Surgery for Nonfunctional Pituitary Adenomas.
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Hormone Replacement | 2015 |
The effects of recombinant human TSH on bone turnover in patients after thyroidectomy.
Topics: Aged; Biomarkers; Bone Remodeling; Calcium; Carcinoma, Papillary; Collagen Type I; Female; Humans; H | 2010 |
Thyroid carcinoma: iodine-131-negative whole-body scan reverses to positive after a combination of thyrogen stimulation and withdrawal.
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; False Negative Reactions; Female; Head and Neck Ne | 2002 |
A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation.
Topics: Adult; Carcinoma, Papillary; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm, Resi | 2002 |
Recombinant human TSH changes the multidisciplinary approach to patients with differentiated thyroid carcinoma. Two-year experience.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Cohort Studies; Female; Follow-Up Studies; Hor | 2003 |
Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Carcinoma, Papillary; Cohort Studies; Drug Administra | 2003 |